血管緊張素Ⅱ受體1(AGTR1)多克隆抗體
Polyclonal Antibody to Angiotensin II Receptor 1 (AGTR1)
AT1R; AG2S; AG2-S; AGTR1A; AGTR1B; AT1; AT1B; AT2R1; AT2-R1; AT2R1A; AT2R1B; HAT1R; AT1 Receptor; Angiotensin Receptor 1B
- 編號PAB658Hu01
- 物種Homo sapiens (Human,人)相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原RPB658Hu01-血管緊張素Ⅱ受體1(AGTR1)重組蛋白
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有0.02% NaN3和50%甘油)
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術,請參見流式抗體。 - 下載英文說明書 中文說明書
- 規(guī)格20μl100μl200μl1ml10ml
- 價格¥ 598 ¥ 1394¥ 1992¥ 4980¥ 19920
- 欲了解實際交易價格和更多情況,請與當?shù)亟?jīng)銷商聯(lián)系!
特異性
該抗體是針對AGTR1的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別AGTR1。
用法
Western blotting: 0.5-2μg/mL;
Immunohistochemistry: 5-20μg/mL;
Immunocytochemistry: 5-20μg/mL;
Optimal working dilutions must be determined by end user.
儲存
經(jīng)常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產(chǎn)生。保質(zhì)期內(nèi),在適當?shù)臈l件下存儲,損失率低于5%。
贈品
增值服務
相關產(chǎn)品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
RPB658Hu02 | 血管緊張素Ⅱ受體1(AGTR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB658Hu03 | 血管緊張素Ⅱ受體1(AGTR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPB658Hu01 | 血管緊張素Ⅱ受體1(AGTR1)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
PAB658Hu01 | 血管緊張素Ⅱ受體1(AGTR1)多克隆抗體 | WB; IHC; ICC; IP. |
MAB658Hu22 | 血管緊張素Ⅱ受體1(AGTR1)單克隆抗體 | WB; IHC; ICC; IP. |
SEB658Hu | 血管緊張素Ⅱ受體1(AGTR1)檢測試劑盒(酶聯(lián)免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
LMB658Hu | 血管緊張素Ⅱ受體1(AGTR1)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
參考文獻
雜志 | 參考文獻 |
Journal of Atherosclerosis and Thrombosis | Involvement of Angiotensin II Type 1 and 2 Receptors in Gelatinase ReCavia (Guinea pig )lation in Human Carotid Atheroma in vitro[Pubmed:26947595] |
European Journal of Pharmaceutical Sciences | Vitamin D3 potentiates the renoprotective effects of vildagliptin in a rat model of fructose/salt-induced insulin resistance[Pubmed: 31866564] |
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY | Vitamin D3 potentiates the nephroprotective effects of metformin in a rat model of metabolic syndrome: Role of AMPK/SIRT1 activation and DPP-4 inhibition[Pubmed: 33108744] |
Fundam Clin Pharmacol | Vitamin D3 potentiates the nephroprotective effects of vildagliptin‐metformin combination in a rat model of metabolic syndrome[34453360] |